DENVER, Nov. 01, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc. a continuous health monitoring and clinical intelligence company, today announced the launch of its patented, FDA-cleared, pulse ...
Fitbit has dropped a patent for a medical grade smart ring, in what could be a dramatic new form factor for the Google-owned company. A filing at the US Patent and Trademark Office (spotted by ...
The Apple Watch’s SpO2 sensor that allows wearers to measure their blood oxygen levels was impressive when it first debuted, but it may be even more accurate than initially marketed. According to a ...
According to BioIntelliSense, several studies of its pulse oximetry chipset have confirmed that it can detect hypoxia with similar accuracy across all skin tones, even when tested on a variety of ...
The MAXREFDES220# reference design provides everything you need to quickly prototype your product to measure finger-based heart rate and blood oxygen saturation level (SpO2). The MAXREFDES220# ...
The critical care team at UCHealth in Colorado reduced the off-label placement of pulse oximetry sensors from 15% to less than 1%, according to an article published in the December issue of Critical ...
Masimo’s revolutionary SET® pulse oximetry has been shown in more than 100 independent and objective studies to outperform other pulse oximetry technologies – even before the revisions that achieved ...
The Movano Evie smart ring has been announced, a health wearable which could compete with the likes of the Oura ring. The gadget has various biometric tracking tools, such as skin temperature and SpO2 ...
Tech Times on MSN
Galaxy Ring gains Korea sleep apnea clearance: optical-motion sensing enables smart ring debut
Galaxy Ring sleep apnea screening now holds South Korean MFDS clearance, making Samsung the first to bring official ...
Irvine, California-based Masimo Technologies, which makes non-invasive patient monitoring devices and sensors, has received FDA 510(k) clearance for its forehead sensor. The adhesive TFA-1 Forehead ...
The recall began earlier this year after GE HealthCare learned that some of its TruSignal SpO2 sensors may be at risk of malfunctioning, which the FDA has linked to flaws in the design of the devices.
GE HealthCare is recalling 7559 TruSignal arterial oxygen saturation (SpO2) sensors because of problems that may reduce defibrillation energy, expose patients to unintended voltage, or give inaccurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results